| Company Name: | Kinetic Concepts, Incorporated | | Ticker Symbol: | KCI | | | WWW Address: | www.kci1.com | | CEO: | Catherine M. Burzik | | No. of Employees: | 6,900 | | Common Issue Type: | CS | | Business Description: | A global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the advanced wound care, regenerative medicine and therapeutic support system markets.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 33.8 |  0.44 | 33.8 | 33.82 | 33.79 | 33.62 | 33.01 | 325799 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 2,406.6 | 71.2 | 0.91 | 2.42 | 0.00 | 11.0 | 0.0 | 39.25 - 17.86 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 33.36 | $ | | PE Ratio - LTM | 11.0 | |
| Market Capitalisation | 2,376.1 | mil |
| Latest Shares Outstanding | 71.2 | mil |
| Earnings pS (EPS) | 2.42 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 272,161 | $ |
| Effective Tax Rate | 39.5 | % |
| Float | 61.5 | mil |
| Float as % of Shares Outstanding | 86.5 | % |
| Foreign Sales | 607 | mil |
| Domestic Sales | 1,271 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 24.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 4.60 | % |
| Gross Profit Margin | 59.5 | % |
| EBITDA Margin | 30.1 | % |
| Pre-Tax Profit Margin | 15.7 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | 7.2 | % |
| Return on Equity (ROE) | 19.6 | % |
| Return on Capital Invested (ROCI) | 9.2 | % |
| Current Ratio | 2.1 | |
| Leverage Ratio (Assets/Equity) | 2.7 | |
| Interest Cover | 3.8 | |
| Total Debt/Equity (Gearing Ratio) | 1.23 | |
| LT Debt/Total Capital | 53.0 | % |
| Working Capital pS | 6.33 | $ |
| Cash pS | 3.79 | $ |
| Book-Value pS | 15.37 | $ |
| Tangible Book-Value pS | -9.72 | $ |
| Cash Flow pS | 5.49 | $ |
| Free Cash Flow pS | 4.08 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.17 | |
| Price/Tangible Book Ratio | -3.43 | |
| Price/Cash Flow | 6.1 | |
| Price/Free Cash Flow | 8.2 | |
| P/E as % of Industry Group | 39.0 | % |
| P/E as % of Sector Segment | 5.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -4.8 | 95 | 10,864 | 53,760 |
| 4 Weeks | 36.42 | 32.83 | 34.62 | -3.6 | 95 | 9,553 | 191,066 |
| 13 Weeks | 39.25 | 31.47 | 33.71 | -1.0 | 93 | 8,745 | 559,669 |
| 26 Weeks | 39.25 | 24.87 | 25.21 | 32.3 | 108 | 7,931 | 1,007,187 |
| 52 Weeks | 39.25 | 17.86 | 21.12 | 58.0 | 116 | 9,444 | 2,370,437 |
| YTD | 39.25 | 18.20 | - | 73.9 | 144 | 9,370 | 2,108,349 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 34.20 | 34.75 | 35.72 | 30.97 | 28.67 | 0.91 | 0.72 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 14.99 | 98.1 | 12.62 |
| Income | 38.02 | 64.1 | 0.81 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 57.53 | NA | 146.51 |
| R&D | 0.00 | NA | 35.65 |
| Normalized Inc. | 30.28 | NA | 4.04 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 5.8 | 0.2 | 16.6 |
| Earnings % | 33.3 | 14.2 | -26.7 |
| EPS % | 36.7 | 16.7 | -26.9 |
| EPS $ | 0.62 | 0.13 | -0.89 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 13.48 |
| Current Ratio | 2.0 |
| Quick Ratio (Acid Test) | 1.6 |
| Liquidity Ratio (Cash) | 0.60 |
| Receivables Turnover | 4.9 |
| Average Collection Period | 73 |
| Working Capital/Equity | 50.0 |
| Working Capital pS | 5.72 |
| Cash-Flow pS | 4.35 |
| Free Cash-Flow pS | -20.55 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.88 |
| Financial Leverage Ratio (Assets/Equity) | 3.7 |
| Debt Ratio | 73.0 |
| Total Debt/Equity (Gearing Ratio) | 2.06 |
| LT Debt/Equity | 1.93 |
| LT Debt/Capital Invested | 74.9 |
| LT Debt/Total Liabilities | 71.5 |
| Interest Cover | 5.2 |
| Interest/Capital Invested | 2.65 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 9.46 |
| Tobin's Q Ratio | 0.79 |
| Current P/E Ratio - LTM | 11.00 |
| Enterprise Value (EV)/EBITDA | 7.94 |
| Enterprise Value (EV)/Free Cash Flow | -2.75 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -3.43 |
| Price/Book Ratio - LTM | 2.17 |
| Price/Cash Flow Ratio | 6.1 |
| Price/Free Cash Flow Ratio - LTM | 8.2 |
| Price/Sales Ratio | 1.21 |
| P/E Ratio (1 month ago) - LTM | 12.5 |
| P/E Ratio (26 weeks ago) - LTM | 12.4 |
| P/E Ratio (52 weeks ago) - LTM | 8.1 |
| 5-Y High P/E Ratio | 174.2 |
| 5-Y Low P/E Ratio | 7.4 |
| 5-Y Average P/E Ratio | 46.4 |
| Current P/E Ratio as % of 5-Y Average P/E | 24 |
| P/E as % of Industry Group | 39.0 |
| P/E as % of Sector Segment | 5.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 11.0 |
| PER SHARE FIGURES |
| LT Debt pS | 22.16 |
| Current Liabilities pS | 5.83 |
| Tangible Book Value pS - LTM | -9.72 |
| Book Value pS - LTM | 15.37 |
| Capital Invested pS | 33.41 |
| Cash pS - LTM | 3.79 |
| Cash Flow pS - LTM | 5.49 |
| Free Cash Flow pS - LTM | 4.08 |
| Earnings pS (EPS) | 2.42 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -77.47 |
| Free Cash Flow Margin 5YEAR AVG | -5.84 |
| Net Profit Margin | 9.3 |
| Net Profit Margin - 5YEAR AVRG. | 11.7 |
| Equity Productivity | 2.32 |
| Return on Equity (ROE) | 21.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 39.5 |
| Capital Invested Productivity | 0.79 |
| Return on Capital Invested (ROCI) | 7.3 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 17.7 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 5.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | 12.9 |
| Gross Profit Margin | 59.5 |
| Gross Profit Margin - 5YEAR AVRG. | 54.2 |
| EBITDA Margin - LTM | 30.1 |
| EBIT Margin - LTM | 21.2 |
| Pre-Tax Profit Margin | 15.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 18.0 |
| Effective Tax Rate | 39.5 |
| Effective Tax Rate - 5YEAR AVRG. | 35.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 112 |
| Revenue per Employee | 272,161 |
| Net Income per Employee | 25,202 |
| Average Collection Period | 78 |
| Receivables Turnover | 4.9 |
| Day's Inventory Turnover Ratio | 34 |
| Inventory Turnover | 10.5 |
| Inventory/Sales | 5.8 |
| Accounts Payble/Sales | 2.86 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 4.63 |
| Fixed Assets Turnover | 0.86 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 7.58 |
| Revenue per $ Plant | 6.18 |
| Revenue per $ Common Equity | 2.32 |
| Revenue per $ Capital Invested | 0.79 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 22.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 22.4 |
| Research & Devlopment (R&D) as % of Revenue | 4.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 4.0 |
|
|  
| | |  |  | |
| |